香港股市 已收市

Zynerba Pharmaceuticals, Inc. (ZYNE)

NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
0.6302+0.0196 (+3.21%)
收市價: 04:00PM EST
0.6200 -0.01 (-1.62%)
收市後: 07:43PM EST
全螢幕
交易股價資料並非來自所有市場
前收市價0.6106
開市0.6400
買盤0.6301 x 1200
賣出價0.6288 x 1100
今日波幅0.6011 - 0.6400
52 週波幅0.4900 - 2.9400
成交量373,859
平均成交量325,747
市值29.659M
Beta 值 (5 年,每月)1.66
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-0.9620
業績公佈日2023年2月27日 - 2023年3月03日
遠期股息及收益率無 (無)
除息日
1 年預測目標價5.44
  • Benzinga

    Zynerba's Cannabidiol Formulated Gel Shows Encouraging Action In Genetic Disease

    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) announced positive top-line results from the Phase 2 INSPIRE trial of Zygel (Transdermal CBD gel) on pediatric behavioral and emotional symptoms of 22q11.2 deletion syndrome. The total score and all five subscales of the Anxiety, Depression, and Mood Scale showed statistically significant improvements at 14 weeks of treatment compared to baseline. All five subscales of the Aberrant Behavior Checklist – Community showed statistically significant improvem